✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Cannabinol is an investigational drug.
There have been 54 clinical trials for Cannabinol. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2009.
The most common disease conditions in clinical trials are Marijuana Abuse, Chronic Pain, and Sclerosis. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Yale University, and Radboud University.
Recent Clinical Trials for Cannabinol
|Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment||University of California, San Diego||Phase 2|
|Cannabinol Use in Patients With Insomnia Disorder||University of Sydney||Phase 1/Phase 2|
|Cannabinol Use in Patients With Insomnia Disorder||Woolcock Institute of Medical Research||Phase 1/Phase 2|